Researchers Submit Patent Application, "Stable Coronavirus Proteins And Vaccine Compositions Thereof", for Approval (USPTO 20250002907).

Researchers have submitted a patent application for "Stable Coronavirus Proteins And Vaccine Compositions Thereof" to address the ongoing threat of the SARS-CoV-2 virus and future emerging coronaviruses. The application focuses on enhancing the stability of the spike protein through specific amino acid mutations to improve vaccine shelf-life. The patent application details methods for identifying mutations and aligning sequences to develop effective vaccines against coronaviruses. [Extracted from the article]